Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

被引:1
作者
Savard, Josee [1 ,2 ,3 ,8 ]
Filion, Catherine [2 ,3 ]
Brearty, Claudia Mc [1 ,2 ,3 ]
Caplette-Gingras, Aude [2 ,4 ]
Chiquette, Jocelyne [2 ,4 ,5 ]
Dorval, Michel [3 ,6 ,7 ]
机构
[1] Univ Laval, Sch Psychol, Quebec City, PQ, Canada
[2] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
[3] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, CHU Quebec, Ctr Maladies Sein, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[7] CISSS Chaudiere Appalaches Res Ctr, Levis, PQ, Canada
[8] Univ Laval, Hop Enfant Jesus, Ctr integre cancerol, CHU Quebec, 1401 18e Rue, Quebec City, PQ G1J 1Z4, Canada
关键词
BRCA1/2 genetic mutation; breast cancer; fear of cancer recurrence; psychological intervention; qualitative study; RISK REDUCTION; THERAPY;
D O I
10.1002/cam4.6889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThere is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated for breast cancer, was to provide a deeper understanding of how FCR is experienced in the context of a genetic predisposition to breast cancer.MethodThree focus groups (90-110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decision to have a prophylactic bilateral mastectomy and/or salpingo-oophorectomy, the effect that surgery had on FCR, and the relevance of offering a psychological intervention targeting FCR to this population.ResultsFindings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FCR interventions that are specifically adapted to the needs of this group.DiscussionThese results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A psychological intervention targeting specifically FCR would be an appropriate complement to preventive surgery.
引用
收藏
页数:12
相关论文
共 50 条
[41]   Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers [J].
Milne, Roger L. ;
Antoniou, Antonis C. .
ENDOCRINE-RELATED CANCER, 2016, 23 (10) :T69-T84
[42]   Predictors of survival for breast cancer patients with a BRCA1 mutation [J].
Steven A. Narod ;
Tomasz Huzarski ;
Jacek Gronwald ;
Tomasz Byrski ;
Elzbieta Marczyk ;
Cezary Cybulski ;
Marek Szwiec ;
Rafal Wisniowski ;
Bozena Birkenfeld ;
Ewa Kilar ;
Robert Sibilski ;
Ping Sun ;
Jan Lubinski .
Breast Cancer Research and Treatment, 2018, 168 :513-521
[43]   Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers [J].
Antonis C Antoniou ;
Andrew Shenton ;
Eamonn R Maher ;
Emma Watson ;
Emma Woodward ;
Fiona Lalloo ;
Douglas F Easton ;
D Gareth Evans .
Breast Cancer Research, 8
[44]   Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer [J].
Mainor, C. B. ;
Isaacs, C. .
CURRENT BREAST CANCER REPORTS, 2020, 12 (02) :66-74
[45]   Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers [J].
Krammer, Julia ;
Pinker-Domenig, Katja ;
Robson, Mark E. ;
Gonen, Mithat ;
Bernard-Davila, Blanca ;
Morris, Elizabeth A. ;
Mangino, Debra A. ;
Jochelson, Maxine S. .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) :565-571
[46]   Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers [J].
Kotsopoulos, Joanne ;
Huzarski, Tomasz ;
Gronwald, Jacek ;
Singer, Christian F. ;
Moller, Pal ;
Lynch, Henry T. ;
Armel, Susan ;
Karlan, Beth ;
Foulkes, William D. ;
Neuhausen, Susan L. ;
Senter, Leigha ;
Tung, Nadine ;
Weitzel, Jeffrey N. ;
Eisen, Andrea ;
Metcalfe, Kelly ;
Eng, Charis ;
Pal, Tuya ;
Evans, Gareth ;
Sun, Ping ;
Lubinski, Jan ;
Narod, Steven A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01)
[47]   Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers [J].
Jane C. Figueiredo ;
Robert W. Haile ;
Jonine L. Bernstein .
Current Breast Cancer Reports, 2009, 1 (3) :139-147
[48]   Survival in Norwegian BRCA1 mutation carriers with breast cancer [J].
Anne Irene Hagen ;
Steinar Tretli ;
Lovise Mæhle ;
Jaran Apold ;
Nina Vedå ;
Pål Møller .
Hereditary Cancer in Clinical Practice, 7
[49]   Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Ikejima, Kengo ;
Tokioka, Sayuri ;
Yagishita, Kazuyo ;
Kajiura, Yuka ;
Kanomata, Naoki ;
Yamauchi, Hideko ;
Kurihara, Yasuyuki ;
Tsunoda, Hiroko .
JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (02) :213-220
[50]   Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers [J].
Kengo Ikejima ;
Sayuri Tokioka ;
Kazuyo Yagishita ;
Yuka Kajiura ;
Naoki Kanomata ;
Hideko Yamauchi ;
Yasuyuki Kurihara ;
Hiroko Tsunoda .
Journal of Medical Ultrasonics, 2023, 50 :213-220